Jennifer Taubert

Taubert, who has helped guide the Janssen Pharmaceutical Companies of Johnson & Johnson during the COVID-19 pandemic, has been honored on the annual list for the fifth year in a row.

The company just released its second-annual report and we’re spotlighting the top takeaways for patients, consumers and healthcare professionals, including a look at how Janssen approaches drug pricing.

Group Worldwide Chair Sandi Peterson and Company Group Chairman, Pharmaceuticals, The Americas Jennifer Taubert are honorees once again this year.

Jennifer Taubert, Executive Vice President, Worldwide Chairman, Pharmaceuticals, Johnson & Johnson, has just been named to Fortune’s 2018 list of powerhouse leaders. We caught up with her to hear about her accomplishments, what inspires her—and what she has her sights set on achieving next.